![David Alastair Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Alastair Smith
Chairman at
THERACRYF PLC
Net worth: 2 M $ as of 2026-05-30
Profile
David Alastair MacLaughlin Smith was the founder of Avacta Group Plc, founded in 2004, where the title held was Chief Executive Officer & Executive Director from 2005 to 2024.
Current jobs include Non-Executive Chairman at SPARTA Biodiscovery Ltd., Non-Executive Chairman at TheraCryf Plc starting in 2025, and Independent Non-Executive Director at Thalia Therapeutics Plc starting in 2025.
Former jobs include Chief Executive Officer & Director at Avacta Life Sciences Ltd., Director-Institute of Molecular Biophysics at the University of Leeds, and Director at TheraGenetics Ltd. Education includes undergraduate and doctorate degrees from The University of Manchester.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVACTA GROUP PLC 0.36% | 2025-06-03 | 1,565,100 ( 0.36% ) | 2 M $ | 2026-05-30 |
THERACRYF PLC 0.19% | 2025-03-30 | 4,000,000 ( 0.19% ) | 12 960 $ | 2026-05-30 |
David Alastair Smith active positions
| Companies | Position | Start |
|---|---|---|
| THALIA THERAPEUTICS PLC | Director/Board Member | 2025-01-07 |
| THERACRYF PLC | Chairman | 2025-02-18 |
Sparta Biodiscovery Ltd.
 Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Chairman | - |
Former positions of David Alastair Smith
| Companies | Position | End |
|---|---|---|
| AVACTA GROUP PLC | Founder | 2024-04-30 |
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | - |
TheraGenetics Ltd.
 TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Director/Board Member | - |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of David Alastair Smith
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Health Technology |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Health Technology |
- Stock Market
- Insiders
- David Alastair Smith
